ACTRN12620001201965Recruiting未知
Assessing change in Anti-Mullerian Hormone (ovarian reserve) associated with surgical excision vs conservative management of endometrioma: A longitudinal cohort study
Keryn Harlow0 sites572 target enrollmentStarted: November 12, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 572
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 25 Years to 37 Years (—)
- Sex
- Female
Inclusion Criteria
- •Women aged 25-37 presenting to: general gynaecology outpatient clinic or Reproductive Services Unit at The Royal Women’s Hospital, or to a level 5 or 6 laparoscopic accredited gynaecologist or fertility specialist at Ramsay Health, Epworth Healthcare, Melbourne IVF or NewLife IVF, or the Endometriosis Centre at Hadassah-Hebrew University Medical Centre in Israel with an ultrasound (USS) diagnosis of endometrioma defined as: the presence of one or more ovarian cysts equal to or greater than 2cm diameter with regular margins and ground glass echogenicity that does not reduce in size over 4 or more weeks.
Exclusion Criteria
- •Endometrioma <2 cm diameter- these patients are more likely to be managed conservatively
- •Factors that can affect ovarian reserve, including previous ovarian surgery, oophorectomy, chemotherapy
- •Suspicion of malignancy- and will therefore be offered surgery
- •Inability to provide informed consent
- •Non-English speaking
- •Previous or planned hysterectomy- as hysterectomy is known to reduce AMH
Investigators
Similar Trials
Completed
Phase 2
Evaluation of the changes of hormone in polycystic ovarian syndrome, following ovarian drillingIRCT20141230020486N4Mashhad University of Medical Sciences30
Completed
Not Applicable
Evaluating the effect of metformine on antimullerian hormone(AMH ) in polycystic ovarian syndrome –a clinical trialPolycystic ovarian syndrome.IRCT2014081918858N1Diabet Research Center, Yazd Shahid Sadoughi Univercity Of Medical Science42
Completed
Not Applicable
Study of Mechanisms of Anovulation in Polycystic Ovary SyndromeAnovulationNCT00492882University Hospital, Lille30
Completed
Not Applicable
Evaluation blood level of anti-m?llerian hormone measurement efficiency in prediction of the response to weight loss diet in obese women with polycystic ovarian syndrome with infertility problem.Obesity in polycystic ovary syndrome women.Polycystic ovarian syndromeIRCT201302241141N14Royan institute80
Completed
Not Applicable
Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)Anti-Mullerian Hormone DeficiencyPost Partum HemorrhageNCT03907605Kanuni Sultan Suleyman Training and Research Hospital88